Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2018, Article ID 3729402, 7 pages
https://doi.org/10.1155/2018/3729402
Research Article

Circulating PGRN Levels Are Increased but Not Associated with Insulin Sensitivity or β-Cell Function in Chinese Obese Children

1Department of Endocrinology, Metabolism and Genetic Disorders, Children’s Hospital of Soochow University, Suzhou, Jiangsu, China
2Department of Cardiology, Children’s Hospital of Soochow University, Suzhou, Jiangsu, China
3Department of Emergency Intensive Care Unit, The First Affiliated Hospital of Soochow University, Jiangsu, China

Correspondence should be addressed to Miao Hou; moc.621@123oaimuoh

Received 21 February 2018; Revised 5 June 2018; Accepted 25 June 2018; Published 29 July 2018

Academic Editor: Francesc Villarroya

Copyright © 2018 Fengyun Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Abella, J. Pino, M. Scotece et al., “Progranulin as a biomarker and potential therapeutic agent,” Drug Discovery Today, vol. 22, no. 10, pp. 1557–1564, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Reinehr, “Long-term effects of adolescent obesity: time to act,” Nature Reviews Endocrinology, vol. 14, no. 3, pp. 183–188, 2018. View at Publisher · View at Google Scholar · View at Scopus
  3. T. M. Brady, “Obesity-related hypertension in children,” Frontiers in Pediatrics, vol. 5, p. 197, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Nakamura, J. J. Fuster, and K. Walsh, “Adipokines: a link between obesity and cardiovascular disease,” Journal of Cardiology, vol. 63, no. 4, pp. 250–259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Ouchi, K. Ohashi, R. Shibata, and T. Murohara, “Adipocytokines and obesity-linked disorders,” Nagoya Journal of Medical Science, vol. 74, no. 1-2, pp. 19–30, 2012. View at Google Scholar
  6. R. Daniel, E. Daniels, Z. He, and A. Bateman, “Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development,” Developmental Dynamics, vol. 227, no. 4, pp. 593–599, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. He and A. Bateman, “Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis,” Journal of Molecular Medicine, vol. 81, no. 10, pp. 600–612, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Qu, H. Deng, and Z. Hu, “Plasma progranulin concentrations are increased in patients with type 2 diabetes and obesity and correlated with insulin resistance,” Mediators of Inflammation, vol. 2013, Article ID 360190, 6 pages, 2013. View at Publisher · View at Google Scholar
  9. A. Hossein-Nezhad, K. Mirzaei, H. Ansar, S. Emam-Gholipour, A. Tootee, and S. A. Keshavarz, “Obesity, inflammation and resting energy expenditure: possible mechanism of progranulin in this pathway,” Minerva Endocrinologica, vol. 37, no. 3, pp. 255–266, 2012. View at Google Scholar
  10. T. Matsubara, A. Mita, K. Minami et al., “PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue,” Cell Metabolism, vol. 15, no. 1, pp. 38–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Tonjes, M. Fasshauer, J. Kratzsch, M. Stumvoll, and M. Bluher, “Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes,” PLoS One, vol. 5, no. 11, article e13911, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Richter, D. Focke, T. Ebert et al., “Serum levels of the adipokine progranulin depend on renal function,” Diabetes Care, vol. 36, no. 2, pp. 410–414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. B. S. Youn, S. I. Bang, N. Kloting et al., “Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue,” Diabetes, vol. 58, no. 3, pp. 627–636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Kloting, M. Fasshauer, A. Dietrich et al., “Insulin-sensitive obesity,” American Journal of Physiology. Endocrinology and Metabolism, vol. 299, no. 3, pp. E506–E515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Tanner, “Growth and maturation during adolescence,” Nutrition Reviews, vol. 39, no. 2, pp. 43–55, 1981. View at Google Scholar
  16. I. M. Libman, E. Barinas-Mitchell, A. Bartucci, R. Robertson, and S. Arslanian, “Reproducibility of the oral glucose tolerance test in overweight children,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 11, pp. 4231–4237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ten and N. Maclaren, “Insulin resistance syndrome in children,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2526–2539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Valerio, M. R. Licenziati, A. Iannuzzi et al., “Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy,” Nutrition, Metabolism, and Cardiovascular Diseases, vol. 16, no. 4, pp. 279–284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Bonora, G. Targher, M. Alberiche et al., “Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity,” Diabetes Care, vol. 23, no. 1, pp. 57–63, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Bacha, N. Gungor, and S. A. Arslanian, “Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test,” The Journal of Pediatrics, vol. 152, no. 5, pp. 618–621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. O. O. Anakwe and G. L. Gerton, “Acrosome biogenesis begins during meiosis: evidence from the synthesis and distribution of an acrosomal glycoprotein, acrogranin, during guinea pig spermatogenesis,” Biology of Reproduction, vol. 42, no. 2, pp. 317–328, 1990. View at Publisher · View at Google Scholar
  22. E. M. Alissa, R. H. Sutaih, H. Z. Kamfar, A. E. Alagha, and Z. M. Marzouki, “Serum progranulin levels in relation to insulin resistance in childhood obesity,” Journal of Pediatric Endocrinology & Metabolism, vol. 30, no. 12, pp. 1251–1256, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Li, B. Zhou, L. Xu et al., “Circulating PGRN is significantly associated with systemic insulin sensitivity and autophagic activity in metabolic syndrome,” Endocrinology, vol. 155, no. 9, pp. 3493–3507, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Smitka and D. Maresova, “Adipose tissue as an endocrine organ: an update on pro-inflammatory and anti-inflammatory microenvironment,” Prague Medical Report, vol. 116, no. 2, pp. 87–111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Yin, R. Banerjee, B. Thomas et al., “Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice,” The Journal of Experimental Medicine, vol. 207, no. 1, pp. 117–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Tanaka, H. Tsukamoto, H. Mitoma et al., “Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity,” Arthritis Research & Therapy, vol. 14, no. 6, p. R244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Wei, A. Hettinghouse, and C. Liu, “The role of progranulin in arthritis,” Annals of the New York Academy of Sciences, vol. 1383, no. 1, pp. 5–20, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. B. P. Chitramuthu, H. P. J. Bennett, and A. Bateman, “Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease,” Brain, vol. 140, no. 12, pp. 3081–3104, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Liu, W. Zhang, F. Yang et al., “Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling,” Scientific Reports, vol. 6, no. 1, article 21260, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. G. C. Weir and S. Bonner-Weir, “Five stages of evolving beta-cell dysfunction during progression to diabetes,” Diabetes, vol. 53, Supplement 3, pp. S16–S21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. B. B. Nicoletto and L. H. Canani, “The role of progranulin in diabetes and kidney disease,” Diabetology and Metabolic Syndrome, vol. 7, no. 1, p. 117, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Xu, B. Zhou, H. Li et al., “Serum levels of progranulin are closely associated with microvascular complication in type 2 diabetes,” Disease Markers, vol. 2015, Article ID 357279, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Mozos, C. Malainer, J. Horbanczuk et al., “Inflammatory markers for arterial stiffness in cardiovascular diseases,” Frontiers in Immunology, vol. 8, p. 1058, 2017. View at Publisher · View at Google Scholar